中国药企出海报告（英）.docx

《中国药企出海报告（英）.docx》由会员分享，可在线阅读，更多相关《中国药企出海报告（英）.docx（74页珍藏版）》请在第壹文秘上搜索。

1、NAVIGATINGG1.OBA1.MARKETSCO-PRODUCEDBYPharmcubeiDeal三命PHARMCUBEEmpowerBiopharmaInnovationAccelerateDecision-makingFoundedin2015,Pharmcubestrivestoreconstructpharmaceuticaldata,bridgetheinformationgap,andthoroughlyempowerinnovation.Byleveragingdataacrossthefulllife-cycleofpharmaceuticalproductsplussc

2、alableandhighlycompatibleAltechnology,Pharmcubehassuccessfullylaunchedovertenenterprise-leveldataproducts,serving1,000+leadingpharmaceuticalcompaniesandinvestmentinstitutions.Wealsoprovideyouwithmediaandconsultingservicesthatfacilitateyourstrategicplanninganddecision-makingandpromotetheinnovationand

3、transformationofthepharmaceuticalindustry.OurIndustryInfluenceOurtrustworthydataandconstantly-improvingservicehavewonclient,sheart.800,000+Millionsof1000+7years1.eadingpharma.AccumuUttionoSubscriboraSearchespermonthcompaniesandinstitutions,choicepharmaceuticaldataWeAreGrowingWeteamupwithtoptalents.O

4、ver56%masterorPh.Dholders,andmorethan60%topuniversitygraduates(suchasPekingUniversity,TsinghuaUniversity,FudanUniversityorShanghaiJiaoTongUniversity),around10%ofthemreceiveeducationinoverseasuniversities.Ourteamofdataspecialistshavenotjustexperiencebutalsothespirittoinnovate.PharmcubeNeXtBiOPharmTM-

5、Timely,accurateandreliableintelligenceonglobalnewdrugsIntroducingNextBiopharm,acutting-edgedatabasemeticulouslycraftedandlaunchedbyPharmcube,designedspecificallytospotlightglobalnewdrugswithunparalleledcoverageintheChinesemarket.Thisplatformseamlesslyintegratesandstandardizesawealthofinformation,inc

6、ludingpatents,literature,clinicaltrials,news,deals,andmarketingdata,providingacomprehensiveoverviewofeverynovelmoleculeworldwide.AsaproudmemberofthePharmcubefamily,NeXtBiOPharmTMTMiswelllinkedwithotherofferingssuchasNextPat,PharmaGO,MedAlpha,etc.,ensuringarobustconnectivitythatcaterstothediverseneed

7、softhepharmaceuticalMini-programClinicalDataKnowledgeCardsNewsandRePOrtSTranslationalScienceCompetitiveIntelligenceDiseaseAnalysisBusinessAnalysisdrugsAnalysisTargetA呵ysisAlCapabilities:Automatedprediction/Auto-FlownnntafinnHumanIntelligence:InsightfulAnalysisDatamonitoringCleansingMndardizationindu

8、stryandinvestorsalike.WebDal三三iDealsVDREmpowers75%ofOut-licensingDealsAsBDtransactionsbecomemorefrequentandactive,iDealsSolutionsprovidesacomprehensiveVDRsolution,whichisasapowerfulassistantforBDtransactionsinthebiopharmaceuticalindustry:thevirtualdataroom(VDR)becomesanindispensabletoolforinformatio

9、ninteractionatatimewhendistancesmakeinformationinteractioninconvenientandtheprocessofbuildingtrustverylengthy.Itsimplifiestheprocessofsharingandmanagingsensitiveandconfidentialdocuments.Itsfinancial-gradedocumentsecuritysolutionensuresthatthecompanysconfidentialdocumentsmeetthemoststringentcomplianc

10、erequirementsinBDtransactionusagescenarios.EmpowerstheentireprocessofcorporateBDtransactions,includingprotectingdatasecurity,supportingduediligenceandauditing,enhancingtransactionefficiency,improvingtransactiontransparency,andreflectinganefficientprofessionalimage.ContactUsPharmcubeContactus：AboutPr

11、oduct/ServicedaisiweiAfter-SalessanyunanForMediaCollaborationzhangxiaoyiiDealsContactus：Trialrequest:iohn.vuaridealscogcomWWWCONTENTSPARTONEFollowthetrendofthetimesFactorscompellingChinesepharmaceuticalcompaniestogoglobal7PARTTWOInsightsontransactionsScenariosanddataofChinesepharmaceuticalcompaniesg

12、oingoverseas18PARTTHREEEarlymoversIn-depthanalysisoftypicalcases24PARTFOURData-baseddecision-makingApplicationofdatainscreeningoverseasopportunities41PARTONEFactorsCompellingChinesePharmaceuticalCompaniestoGoGlobalIInrecentyears,Chinesepharmaceuticalcompanieshavebeentakingtheinitiativetotapintothegl

13、obalmarketasaresultofanumberoffactors.lntensecompetitionwithintheChinesemarketisdrivingcompaniestoseekoutopportunitiesforsurvivalspaceinoverseasmarkets.Themedicalinsurancepaymentreformandrestrictedhospitalaccesshavesqueezedtheprofitmarginsofinnovativedrugs.Additionally,somesectorswithintheindustryha

14、vewitnessedfiercecompetitionsurroundinghomogeneousproducts.Consequently,someChinesecompaniesareturningtotheglobalmarketfornewgrowthspaceandstrongerprofitability.IFacedwithfinancialchallenges,manycompaniesarechoosingtoseekinvestmentandcollaboratewithothersinordertostayinbusiness.Thepharmaceuticalindu

15、stryisexperiencingdownwardpressure,withmostcompanieshavingdifficultyinfundingandcashflows.Inlightofthis,relinquishingaportionoftheirinterestsintheoverseasmarketinreturnforcashandsubsequentfundingpresentsanadvantageoussurvivalstrategyformostcompanies.IWithgrowingstrengthinR&Dofnewdrugs,Chinesecompaniesshowstrongerglobalcompetitiveness.Asmoretale